K-numberK252906
Device nameECHELON ENDOPATH Staple Line Reinforcement (ECH60R)
ApplicantEthicon Endo-Surgery, LLC
Product codeOXC
Device classClass II
Decision dateJan 9, 2026
DecisionSubstantially Equivalent
Regulation878.3300
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

ECHELON ENDOPATH Staple Line Reinforcement (ECH60R) is an absorbable surgical mesh buttress used to reinforce staple lines during soft tissue transection or resection. It is applied to surgical staplers and works as an adjunct to staples to support soft tissue healing. The device is indicated for use in lung resection, bariatric, gastric, small bowel, and colorectal surgical procedures.

Technological characteristics

The subject device is identical to the predicate in all physical and material characteristics: same absorbable composition (Polyglactin 910 Vicryl knit laminated with Polydioxanone film), same dimensions (65.367 ± 0.30 mm length, 10.4 ± 0.30 mm width), same applicator design, and same 120-day absorption rate. The only differences are increased maximum sterilization dose from 25-30 kGy to 25-40 kGy and extended shelf life from 2 years to 3 years.

Test standards cited

ISO 10993-1 for biocompatibility guidance. Non-clinical testing included staple pull-through, buttress alignment, release force, packaging seal strength, and comprehensive biocompatibility studies (cytotoxicity, sensitization, pyrogenicity, genotoxicity, subcutaneous implantation at 4 weeks and 13 weeks). A GLP canine gastric study was conducted at 40 kGy with endpoints at 10, 28, and 120 days to support the increased sterilization dose.

Substantial equivalence argument

Substantial equivalence is based on identical intended use, indications for use, design, materials, and device performance. There are no modifications to device design or materials compared to predicate K221343. The increased sterilization dose and shelf life are supported by non-clinical biocompatibility and implantation studies demonstrating the device maintains safety and effectiveness. No clinical data were required as the device is substantially equivalent with no new safety or effectiveness questions raised.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →